Published in PLoS One on December 26, 2014
Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30
Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations. Biotechnol Lett (2004) 18.55
Biology of natural killer cells. Adv Immunol (1989) 14.77
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75
Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol (2007) 11.04
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Interferons, immunity and cancer immunoediting. Nat Rev Immunol (2006) 8.23
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature (2005) 7.18
Metastases to the heart. Ann Oncol (2004) 5.51
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol (2001) 5.48
Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J (2005) 4.91
Cardiac metastases. J Clin Pathol (2006) 4.41
The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia (2004) 3.54
Mechanisms linking physical activity with cancer. Nat Rev Cancer (2008) 3.50
NK cell development, homeostasis and function: parallels with CD8⁺ T cells. Nat Rev Immunol (2011) 3.38
Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol (2013) 3.23
The optical stretcher: a novel laser tool to micromanipulate cells. Biophys J (2001) 3.14
Tumour phospholipid metabolism. NMR Biomed (1999) 2.74
NKG2D ligands in tumor immunity. Oncogene (2008) 2.26
Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. Biophys J (2005) 2.11
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest (2009) 2.08
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood (2004) 1.95
Human natural killer cell development and biology. Blood Rev (2005) 1.83
Optical deformability of soft biological dielectrics. Phys Rev Lett (2000) 1.73
Recognition of autologous dendritic cells by human NK cells. Eur J Immunol (1999) 1.63
Label-free detection of mitochondrial distribution in cells by nonresonant Raman microspectroscopy. Biophys J (2007) 1.55
Structure similarity, difference and variability in the filamentous viruses fd, If1, IKe, Pf1 and Xf. Investigation by laser Raman spectroscopy. J Mol Biol (1983) 1.41
Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control (2011) 1.34
Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions. J Biomech (2004) 1.32
CARCINOGENESIS THROUGH SOLID STATE SURFACES. Prog Exp Tumor Res (1964) 1.25
Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer (2012) 1.16
A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int (1995) 1.13
Nano-patterned SERS substrate: application for protein analysis vs. temperature. Biosens Bioelectron (2008) 1.13
Demonstration of a fiber-optical light-force trap. Opt Lett (1993) 1.08
A fluorescence NK assay using flow cytometry. J Immunol Methods (1986) 1.06
Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages. PLoS One (2013) 1.02
Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness. Proc Natl Acad Sci U S A (2014) 0.92
Phospholipid composition and electric charge in healthy and cancerous parts of human kidneys. J Membr Biol (2013) 0.89
Imaging live cells grown on a three dimensional collagen matrix using Raman microspectroscopy. Analyst (2010) 0.84
Palpation imaging using a haptic system for virtual reality applications in medicine. Stud Health Technol Inform (2004) 0.84
3D confocal Raman imaging of endothelial cells and vascular wall: perspectives in analytical spectroscopy of biomedical research. Analyst (2013) 0.84
Microfluidic devices modulate tumor cell line susceptibility to NK cell recognition. Small (2012) 0.83
Methods for extracting biochemical information from bacterial Raman spectra: an explorative study on Cupriavidus metallidurans. Anal Chim Acta (2007) 0.82
Raman database of amino acids solutions: a critical study of extended multiplicative signal correction. Analyst (2013) 0.82
Effect of high energy shock waves on tumor cells. Urol Res (1990) 0.81
Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level. J Biomed Opt (2010) 0.81
Microfluidic biofunctionalisation protocols to form multi-valent interactions for cell rolling and phenotype modification investigations. Electrophoresis (2013) 0.80
High-energy shock waves: in vitro effects. Am J Kidney Dis (1991) 0.79
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle (2011) 2.43
The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood (2008) 2.24
Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J Immunol (2012) 1.11
In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2. Eur J Immunol (2010) 1.01
Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS One (2010) 0.96
New views on natural killer cell-based immunotherapy for melanoma treatment. Trends Immunol (2010) 0.91
Distinct and overlapping patterns of cytokine regulation of thymic and bone marrow-derived NK cell development. J Immunol (2009) 0.86
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells. J Immunol (2009) 0.86
Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level. J Biomed Opt (2010) 0.81
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia (2014) 0.78
A novel facet of tumor suppression by p53: Induction of tumor immunogenicity. Oncoimmunology (2012) 0.77
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors. Eur J Immunol (2015) 0.76